Kader Thiam, PhD

CSO and Senior VP at genOway

Speaker

Kader Thiam received his Ph.D. for work at The Pasteur Institute, Lille, in cellular immunology and infectious diseases before becoming a fellow in its Department of Peptide Chemistry. There, he focused on regulating immune response using recombinant viruses and synthetic agonists of cytokines, and on intracellular delivery of lipopeptides modulating pharmacological targets.

Kader Thiam joined genOway in 1999, serving first as Scientific Consultant and Head of Immunology, and later as Director of Transgenic Technologies, driving R&D programs to develop alternatives to overcome transgenesis limitations and new models for immune response monitoring and better predictability toward the human situation. He is currently CSO and Senior VP overseeing the feasibility, design, rationale and accuracy of genOway’s preclinical models.